Document:

Exhibit
10.8

 

EMPLOYMENT AGREEMENT

 

This
Employment Agreement (the “Agreement”) is
entered into effective November 22, 2010 (the “Effective Date”), by and between Michael Keriakos
(the “Employee”) and Everyday Health, Inc. (the “Company”).

 

The
Company desires to employ the Employee and, in connection therewith, to compensate the Employee for Employee’s personal
services to the Company; and

 

The
Employee wishes to be employed by the Company and provide personal services to the Company in return for certain compensation.

 

Accordingly,
in consideration of the mutual promises and covenants contained herein, the parties agree to the following:

 

1.
Employment by the Company.

 

1.1 Term.
The term of this Agreement shall commence on the Effective Date, and shall continue through November 22, 2013, unless
terminated prior thereto by either the Company or the Employee as provided in Section 5. If either the Company or the
Employee does not wish to renew this Agreement when it expires at the end of the initial or any renewal term hereof, as
hereinafter provided, it or he shall give written notice in accordance with Section 6.1 below of such intent to the other
party at least sixty (60) days prior to the expiration date. In the absence of such notice, this Agreement shall be renewed
on the same terms and conditions contained herein for a term of one (1) year from the date of expiration. The parties
expressly agree that designation of a term and renewal provisions in this Agreement does not in any way limit the right of
the parties to terminate this Agreement at any time as hereinafter provided. Reference herein to the “Term” of
this Agreement shall refer both to the initial term and any successive term as the context requires.

 

1.2
Position. Subject to the terms set forth herein, the Company agrees to employ Employee in the position of President and Employee
hereby accepts such employment. During the term of Employee’s employment with the Company, Employee will devote Employee’s
best efforts and substantially all of Employee’s business time and attention to the business of the Company.

 

1.3
Duties. Employee will report to the Chief Executive Officer (“CEO”) of the Company, performing such duties
as are normally associated with his then current position and such duties as are assigned to him from time to time, provided such
duties are not materially inconsistent with his position as President, subject to the oversight and direction of the CEO and the
Board of Directors of the Company (the “Board”). Employee shall perform his duties under
this Agreement principally out of the Company’s corporate headquarters. In addition, the Employee shall make such business
trips to such places as may be necessary or advisable for the efficient operations of the Company.

 

1.4
Company Policies and Benefits. The employment relationship between the parties shall also be subject to the Company’s
personnel policies and procedures as they may be interpreted, adopted, revised or deleted from time to time in the Company’s
sole discretion.

    	 

    	

    

The
Employee will be eligible to participate on the same basis as similarly situated employees in the Company’s benefit plans
in effect from time to time during his employment. All matters of eligibility for coverage or benefits under any benefit plan shall
be determined in accordance with the provisions of such plan. The Company reserves the right to change, alter, or terminate any
benefit plan in its sole discretion. Notwithstanding the foregoing, in the event that the terms of this Agreement differ from,
or are in conflict with, the Company’s general employment policies or practices, this Agreement shall control. While this
Agreement is in effect the Employee shall be eligible to accrue and use five (5) weeks of paid vacation per annum, such vacation
to be accrued and administered pursuant to the Company’s vacation policy.

 

2.
Compensation.

 

2.1
Salary. Employee shall receive for Employee’s services to be rendered hereunder an initial annualized base salary
of $375,000, subject to review and increase from time to time by the Company in its sole discretion, and payable subject to standard
federal and state payroll withholding requirements in accordance with Company’s standard payroll practices (“Base
Salary”).

 

2.2 Bonus.

 

(a)
During Employment. Employee shall be eligible for an annual calendar year bonus (the “Annual Bonus”),
with a target of 100% of his then current Base Salary. The amount of the actual bonus awarded, if any, will be determined
by the Board in its sole discretion based on the Employee’s continuous performance of services to the Company through the
date the Annual Bonus is paid and upon achievement of Company performance objectives and individual performance objectives, such
objectives as set by the CEO and the Board. The 2010 objectives have been set and have been communicated to the Employee. A bonus
earned pursuant to this Section 2.2(a) will be paid on or before March 15 of the year following the year for which it is earned.

 

(b)
Upon Termination. In the event Employee leaves the employ of the Company for any reason prior to payment of any Annual
Bonus, he is not eligible for an Annual Bonus, prorated or otherwise, except as a component of severance as provided in Section
5 below.

 

2.3
Expense Reimbursement. The Company will reimburse Employee for reasonable business expenses in accordance with the
Company’s standard expense reimbursement policy.

    	2

    	

    

3.
Confidential Information, Inventions, Company Property, Non-Solicitation, and Non-Competition
Obligations

 

3.1 Confidential
Information and Return of Company Property.

 

(a)
Employee shall hold in strict confidence and shall not, either during the term of this Agreement or after the termination hereof,
disclose, directly or indirectly, to any third party, person, firm, corporation or other entity, irrespective of whether such
person or entity is a competitor of the Company or is engaged in a business similar to that of the Company, any Confidential Information
(as define in Section 3.3) of the Company or any subsidiary or Affiliate (as defined in Section 3.3) of the Company obtained or
developed by the Employee from, through, or in the course of Employee’s employment hereunder.

 

(b)
Notwithstanding the foregoing limitations, the Employee shall not be required to keep confidential any information that: (i)
is known or available through other lawful sources, or (ii) is or becomes Publicly Known or generally known in the industry through
no fault of the Employee, Employee’s agents or another individual or entity that owes a duty of confidentiality to the Company,
or (iii) is required to be disclosed pursuant to any statutes, laws, rules, regulations, ordinances, codes, directives, writs,
injunctions, decrees, judgments, and orders of any governmental body (provided the Company is given reasonable prior notice).

 

(c)
At any time requested by the Company and/or at termination of the Employee’s employment for any reason, Employee will
promptly deliver to the Company or permanently destroy all property and materials in any form belonging to or relating to the
Company, its business and the business of any of its Customers or Potential Customers (as defined in Section 3.3) (the “Company
Property”). Following such request by the Company or termination of employment, the Employee shall not download
or keep copies of Company Property in any hard or soft format and shall certify in writing that all Company Property has been
returned to the Company or permanently destroyed.

 

(d) Employee shall not publicly
disparage the Company, its business or its employees.

 

3.2 Non-Competition
and Non-Solicitation Agreement. Employee agrees that, during Employee’s employment hereunder, and for a period
of one (1) year (the “Non-Compete Period”) after the later of the effective date of
termination of this Agreement, or the date of entry by a court of competent jurisdiction of a final judgment enforcing this
covenant. Employee will not, as an officer, director, employee, consultant, owner, partner, or in any other capacity,
either directly or through others, in any location where the Company has engaged in business, without the written approval of
the Board:

 

(a) solicit, contact, perform or offer to perform Conflicting Services (as defined in Section 3.3);

 

(b) request, induce, or attempt to induce any Customer or Potential Customer to terminate or reduce its relationship with
the Company or any subsidiary or

    	3

    	

    

Affiliate
of the Company, solicit, contact, perform or offer to or perform any Conflicting Services for a Customer or Potential
Customer.

 

(c)
interfere with or disrupt, or attempt to interfere with or disrupt, the relationship, contractual or otherwise, between the
Company, or any subsidiary or Affiliate of the Company, and any customer, vendor, licensor, supplier or employee of the Company
or any subsidiary or Affiliate of the Company;

 

(d)
offer employment to any person who is a then current employee of the Company or any subsidiary or Affiliate of the Company
or has left the Company or any subsidiary or Affiliate of the Company in the preceding three (3) months, or solicit (directly
or indirectly, individually or in connection with any new employer or other business partner) any person who is a then current
employee of the Company or any subsidiary or Affiliate of the Company or has left the Company or any subsidiary or Affiliate in
the preceding three (3) months to accept employment elsewhere.

 

3.3 Defined Terms.
The following terms shall have the meanings set forth below:

 

(a)
“Affiliate” means any person, firm or corporation, directly or indirectly through one or
more intermediaries, controlling, controlled by or under common control with the Company.

 

(b)
“Confidential Information” means any information used by or belonging or related to the company
or any of its affiliates that is not known generally to the industry in which the Company is or may be engaged and which the Company
maintains on a confidential basis including without limitation any and all intellectual property, trade secrets and proprietary
information, information relating to the Company’s business and services, employee information, customer lists and records,
business processes, procedures or standards, know-how, technology, business strategies, records, financial information, in each
case whether or not reduced to writing or stored electronically, as well as any information that the Company advises the Employee
should be treated as confidential information (including information conceived, discovered or developed by Employee), that he
learns of, possesses, or to which he has access through his employment by the Company, related to the Company, its business partners,
or the business of its Customers or Potential Customers, Confidential Information shall not include information known to Employee
prior to his employment with the Company. Confidential Information shall not include Company information which is or becomes Publicly
Known through no breach of this Agreement or other act or omission of the Employee. The burden of proving that information or
skills and experience are not Confidential Information shall be on the party asserting such exclusion.

 

(c)
“Conflicting Services” means any product, service or process of any person or organization other
than the Company, which directly competes with a product, service or process with which the Employee works during employment by
the Company or about which the Employee acquires Confidential Information during Employee’s employment by the Company.

    	4

    	

    

(d)
“Customer or Potential Customer” means each and every person and/or entity who or which, at any
time during the two (2) years prior to termination of Employee’s employment whom or which the Employee knew or should have
been aware: (i) contracted for, was billed for, or received services from the Company, or (ii) was in contact with the Employee
or in contact with another representative of the Company concerning the Company’s products and services.

 

(e)
“Publicly Known” shall mean readily accessible to the public in a written publication, and shall
not include information which is only available by a substantial searching of the published literature, and information the substance
of which must be pieced together from a number of different publications and sources.

 

3.4
Assignment and Disclosure of Inventions.

 

(a)
From and after the date the Employee first became employed with the Company, the Employee hereby agrees to promptly disclose
in confidence to the Company all inventions, improvements, designs, original works of authorship, formulas, processes, compositions
of matter, computer software programs, databases, mask works, and trade secrets (“Inventions”), whether
or not patentable, copyrightable or protectable as trade secrets, that are made or conceived or first reduced, to practice or
created by the Employee, either alone or jointly with others, during the period and in the course of the Employee’s employment
and which relate in any way to the business of the Company.

 

(b)
Employee hereby acknowledges that copyrightable works prepared by the Employee within the scope of the Employee’s employment
are “works for hire” under the United States Copyright Act and that the Company will be considered the author thereof.
The Employee hereby agrees that all Inventions that (a) are developed using equipment, supplies, facilities or trade secrets of
the Company, (b) result from work performed by the Employee for the Company, or (c) relate to the Company’s business or
current or anticipated research and development, will be the sole and exclusive property of the Company and are hereby assigned
by the Employee to the Company.

 

(c)
Employee agrees to assign and does hereby assign to the Company or its designee all Employee’s
right, title and interest in and to all Inventions related to the business of the Company from time-to-time (whether past, present,
or future) and all related patents, patent applications, copyrights and copyright applications. However, this Section 3.4(c) shall
not apply to Inventions which do not relate to the present or planned business or research and development of the Company and
which are not made and conceived by the Employee during normal working hours, on the Company’s premises and/or using the
Company’s tools, devices, equipment or proprietary information. The Employee understands that, to the extent this Agreement
shall be construed in accordance with the laws of any state which precludes a requirement in an employee agreement to assign
certain classes of inventions made by an employee, this Section 3.4(c) shall be interpreted not to apply to any invention which
a court of competent jurisdiction rules and/or the Company agrees falls within such classes. The Employee also hereby expressly
waives all claims to moral rights in any Inventions.

    	5

    	

    

(d)
Employee agrees to cooperate fully with the Company, both during and after Employee’s employment with the Company, with
respect to the procurement, maintenance and enforcement of copyrights, patents and other intellectual property rights (both in
the United States and foreign countries) relating to Inventions. The Employee shall sign all papers, including, without limitation,
copyright applications, patent applications, declarations, oaths, formal assignments, assignments of priority rights, and powers
of attorney, which the Company may deem necessary or desirable in order to protect its rights and interests in any Development.
The Employee further agrees that if the Company is unable, after reasonable effort, to secure the signature of the Employee on
any such papers, any Employee officer of the Company shall be entitled to execute any such papers as the agent and the attorney-in-fact
of the Employee, and the Employee hereby irrevocably designates and appoints each Employee officer of the Company as Employee’s
agent and attorney-in-fact to execute any such papers on Employee’s behalf, and to take any and all actions as the Company,
in its sole discretion, may deem necessary or desirable in order to protect its rights and interests in any Invention, under the
conditions described in this sentence.

 

3.5
Publication of Covenants to Subsequent Employers or Business Associates of Employee. Employee agrees that if Employee
is offered employment or the opportunity to enter into any business venture as owner, partner, consultant or other capacity in
a business while the covenants in Section 3 of this Agreement are in effect, Employee will inform Employee’s potential employer,
partner, co-owner and/or others involved in managing the business which Employee had an opportunity to join of the existence of
this Agreement and will provide such person or persons with a copy of this Agreement. Employee authorizes the Company to provide
copies of this Agreement to any of the persons or entities described above and to make such persons aware of Employee’s
obligations under this Agreement.

 

3.6
Injunctive Relief from Violation of Section 3. Employee recognizes that irreparable damage will result to the Company
in the event of the violation of any covenant contained in Section 3 and agrees that in the event of such violation, the Company
shall be entitled, in addition to its other legal or equitable remedies and damages, to temporary and permanent injunctive relief
to restrain against such violation(s) thereof by Employee and by all other persons acting for or with Employee, including the
cost of reasonable attorney’s fees.

 

3.7
Reasonableness of Restrictions. Employee and the Company agree that
they have attempted to restrict Employee’s
activities to a reasonable degree appropriate to protect the interests of the
Company, although they agree that others may disagree about this determination.
Therefore, Employee and the Company agree that a court or other trier of fact,
may modify and enforce these restrictions to the minimum extent deemed necessary
to be found reasonable. If a court declines to modify and enforce this Agreement
as provided above, the Employee and the Company agree that this Agreement will
be automatically modified to provide the Company with the maximum protection
of its business interests allowed by law and the Employee agrees to be bound
by this Agreement as modified. Employee further acknowledges and agrees that
if such Employee’s employment is terminated with or without Cause.
Employee’s experience and capabilities are such that Employee can obtain
employment in businesses engaged in other lines and/or of a different nature,
and that enforcement of the restrictions in this agreement by restraining order,
injunction or otherwise will not prevent Employee from earning a livelihood or
cause Employee irreparable harm.

    	6

    	

    

3.8
Survival. The provisions of Section 3 of this Agreement shall survive the termination of Employee’s employment
with the Company and the termination of this Agreement.

 

4.
Outside Activities. Except with the prior written consent of the Company’s
Board, Employee will not, while employed by the Company, undertake or engage in any other employment, occupation or business enterprise
that would interfere with Employee’s responsibilities and the performance of Employee’s duties hereunder.

 

5.
Termination Of Employment. The parties acknowledge that either Employee
or the Company may terminate the employment relationship at any time, with or without Cause or Good Reason. The provisions in
this Section govern the amount of compensation, if any, to be provided to Employee upon termination of employment and do not limit
the right of either party to terminate this Agreement.

 

5.1 Termination
by the Company Without Cause.

 

(a)
The Company shall have the right to terminate Employee’s employment with the Company pursuant to this Section 5.1 at
any time without “Cause” (as defined in Section 5.2(b) below) by giving notice as described in Section 5.6
of this Agreement. A termination pursuant to Section 5.5 below is not a termination without “Cause” for purposes of
receiving the benefits described in this Section 5.1. If the Company provides written notice to the Employee pursuant to Section
1.1 of its intent not to renew this Agreement, then the expiration of this Agreement shall be considered a termination without
Cause.

 

(b)
In the event Employee’s employment is terminated without Cause, pursuant to the Company’s standard payroll policies,
the Company shall pay to Employee the accrued but unpaid salary of Employee through the date of termination, together with all
compensation and benefits payable to Employee based on his participation in any compensation or benefit plan, program or arrangement
through the date of termination. Provided that Employee’s termination without Cause constitutes a Separation From Service
(as defined below), and provided the Employee executes a general release in favor of the Company, in a form acceptable to the
Company (the “Release”), and subject to Section 5.1(c) (the date that the Release becomes effective
and may no longer be revoked by the Employee is referred to as the “Release Date”), then the Company
shall (i) pay to Employee an amount equal to the sum of (A) Employee’s then current Base Salary for a period of twelve (12)
months from the date of Separation From Service (such applicable period is referred to as the “Severance Period”)
plus (B) an amount equal to Employee’s target bonus, less applicable withholdings and deductions, with such sum paid in
equal installments on the Company’s regular payroll dates running from the Separation From Service; provided, however,
that no payments will be made prior to the day that is sixty (60) days following the date of Separation From Service, and on such
date, the Company will make the first payment to Employee under this Section 5.1(b)(i), in a lump sum, equal to the aggregate
amount of salary continuation that the Company would have paid to Employee through such date had the payments commenced on the
Separation From Service through such 60th day, with the balance paid thereafter on the schedule described above; (ii)
Employee shall be credited with an additional year of service

    	7

    	

    

credit
from the date of termination for purposes of vesting any outstanding equity awards; and (iii) if Employee is participating in
the Company’s employee group health insurance plans on the effective date of termination, and timely elects and remains
eligible for continued coverage under COBRA, or, if applicable, state or local insurance laws, the Company shall pay to Employee,
on the first day of each month, a fully taxable cash payment equal to the applicable COBRA premiums for that month (including
premiums for Employee and his eligible dependents who have elected and remain enrolled in such COBRA coverage), subject to applicable
tax withholdings (such amount, the “Special Cash Payment”), for a number of months equal to the lesser
of (i) the duration of the period in which Employee and his eligible dependents are enrolled in such COBRA coverage (and not otherwise
covered by another employer’s group health plan) and (ii) twelve (12) months. Employee may, but is not obligated to, use
such Special Cash Payment toward the cost of COBRA premiums. On the 60th day following Employee’s Separation
From Service, the Company will make the first payment to Employee under this Section 5.l(b)(ii), in a lump sum, equal to the aggregate
Special Cash Payments that the Company would have paid to Employee through such date had the Special Cash Payments commenced on
the first day of the first month following the Separation From Service through such 60th day, with the balance of the
Special Cash Payments paid thereafter on the schedule described above. In the event Employee becomes covered under another employer’s
group health plan or otherwise ceases to be eligible for COBRA during the period provided in this Section 5.1(b)(ii), Employee
must immediately notify the Company of such event and the Company shall cease payment of the Special Cash Payments.

 

(c) Employee shall not
receive any of the benefits pursuant to Section 5.1(b) unless he executes the Release within the consideration period specified
therein, which shall in no event be more than 45 days, and until the Release becomes effective and can no longer be revoked by
Employee under its terms. In all cases, the Release must be signed and effective not later than the 60th day following
Employee’s Separation From Service. Employee’s ability to receive benefits pursuant to Section 5.1(b) is further
conditioned upon his: complying with his termination and post-termination obligations under this Agreement and any other agreements
between Employee and the Company and complying with the Release including without limitation any confidentiality provisions contained
therein.

 

(d)
The benefits provided to Employee pursuant to this Section 5.1 are in lieu of, and not in addition to, any benefits to which
Employee may otherwise be entitled under any Company severance plan, policy or program.

 

(e)
The damages caused by the termination of Employee’s employment without Cause would be difficult to ascertain; therefore,
the severance for which Employee is eligible pursuant to Section 5.1(b) above in exchange for the Release is agreed to by the
parties as liquidated damages, to serve as full compensation, and not a penalty.

    	8

    	

    

5.2 Termination
by the Company for Cause.

 

(a)
Subject to Section 5.2(c) below, the Company shall have the right to terminate Employee’s employment with the Company
at any time for Cause by giving notice as described in Section 5.6 of this Agreement.

 

(b) “Cause”
for termination shall mean that the Company has determined in its sole discretion that the Employee has engaged in any of the
following: (i) a material breach of any covenant or condition under this Agreement or any other written agreement between the
parties; (ii) any act constituting material dishonesty, fraud, or disreputable conduct or moral turpitude; (iii) any conduct
which constitutes a felony under applicable law; (iv) violation of any Company policy or any act of misconduct in either case
causing harm to the Company or its reputation; (v) refusal to follow or implement a clear and lawful directive of CEO or the
Board; (vi) gross negligence or gross incompetence in the performance of Employee’s duties to the Company; or (vii)
breach of fiduciary duty, provided that if Cause is based on the occurrence of one or more of the events specified in
Section 5.2(b)(i), (v) or (vi) of this Agreement, and the Company deems the circumstance constituting Cause to be
curable, the Company will give the Employee written notice as described in Section 5.6 of this Agreement that the Company
intends to terminate the Employee’s employment for Cause on the thirtieth (30th) day following the Employee’s
receipt of the Company’s notice, if the Employee has not cured the circumstances constituting Cause before the end of
such thirty (30) day period.

 

(c)
In the event Employee’s employment is terminated at any time for Cause, Employee will
not receive severance payments, or any other severance compensation or benefit, except that, pursuant to the Company’s standard
payroll policies, the Company shall pay to Employee the accrued but unpaid salary of Employee through the date of termination,
together with all compensation and benefits payable to Employee based on his participation in any compensation or benefit plan,
program or arrangement through the date of termination.

 

5.3 Resignation
by the Employee.

 

(a)
Employee may resign from Employee’s employment with the Company at any time by giving
notice as described in Section 5.6. If the Employee provides written notice to the Company pursuant to Section 1.1 of his intent
not to renew this Agreement, then the expiration of this Agreement shall be considered a resignation without Good Reason.

 

(b)
In the event Employee resigns from Employee’s employment with the Company (other than for Good Reason as set forth in
Section 5.4), Employee will not receive severance payments, or any other severance compensation or benefit, except that, pursuant
to the Company’s standard payroll policies, the Company shall pay to Employee the accrued but unpaid salary of Employee
through the date of resignation, together with all compensation and benefits payable to Employee through the date of resignation
under any compensation or benefit plan, program or arrangement during such period and Employee shall

    	9

    	

    

be eligible for any benefit continuation or conversion rights provided by the
provisions of a benefit plan or by law.

 

5.4 Resignation
by the Employee for Good Reason.

 

(a) Provided
Employee has not previously been notified of the Company’s intention to terminate Employee’s employment, the
Employee may resign from employment with the Company for Good Reason (as defined in Section 5.4(b) below), within ten (10)
days after the occurrence of one of the events specified in Section 5.4(b) below, by giving notice as described in
Section 5.6 of this Agreement that Employee intends to terminate his employment for Good Reason on the thirtieth (30) day
following the Company’s receipt of Employee’s notice, if the Company has not cured the event that gives rise to
Good Reason before the end of such thirty (30) day period.

 

(b)
“Good Reason” for resignation shall mean the occurrence of any of the following without the
Employee’s prior written consent: (i) the assignment to Employee of any duties or responsibilities which result in the material
diminution of Employee’s then current position; (ii) a material reduction by the Company in Employee’s annual base
salary; or (iii) relocation of the Employee’s principal place of business more than thirty-five (35) miles from its then
current location. Notwithstanding the foregoing, any actions taken by the Company to accommodate a disability of the Employee
or pursuant to the Family and Medical Leave Act shall not be a Good Reason for purposes of this Agreement.

 

(c)
In the event Employee resigns from Employee’s employment for Good Reason, pursuant to the Company’s standard payroll
policies, the Company shall pay to Employee the accrued but unpaid salary of Employee through the date of termination, together
with all compensation and benefits payable to Employee based on his participation in any compensation or benefit plan, program
or arrangement through the date of termination and, subject to Section 5.4(d), and provided Employee’s resignation constitutes
a Separation From Service, the Employee shall be eligible for the same payments and benefits as Employee would receive under
Section 5.1 and on the same conditions as if Employee had been terminated by the Company without Cause, provided that Employee
executes a Release of claims in favor of the Company as defined in Section 5.1(b).

 

(d)
Employee shall not receive any of the benefits pursuant to Section 5.4(c) unless he executes
the Release within the consideration period specified therein, which shall in no event be more than 60 days, and until the Release
becomes effective and can no longer be revoked by Employee under its terms. In all cases, the Release must be signed and effective
not later than the 60th day following Employee’s Separation From Service. Employee’s ability to receive
benefits pursuant to Section 5.4(c) is further conditioned upon his: returning all Company property; complying with his post-termination
obligations under this Agreement and any other agreements between Employee and the Company, and complying with the Release including
without limitation any confidentiality provisions contained therein.

    	10

    	

    

(e)
The benefits provided to the Employee pursuant to this Section 5.4 are in lieu of, and not in addition to, any benefits to
which Employee may otherwise be entitled under any Company severance plan, policy or program.

 

(f)
The damages caused by the termination of Employee’s employment without Cause would be difficult to ascertain; therefore,
the severance for which Employee is eligible pursuant to Section 5.4(c) above in exchange for the Release is agreed to by the
parties as liquidated damages, to serve as full compensation, and not a penalty.

 

5.5 Termination
by Virtue of Death or Disability of the Employee.

 

(a)
In the event of Employee’s death while employed pursuant to this Agreement, all obligations of the parties hereunder
shall terminate immediately, the Employee’s legal representatives shall not be eligible to receive severance payments, or
any other severance compensation or benefit, except that the Company shall, pursuant to the Company’s standard payroll policies,
pay to the Employee’s legal representatives Employee’s accrued but unpaid salary through the date of death together
with all compensation and benefits payable to Employee based on his participation in any compensation or benefit plan, program
or arrangement through the date of termination.

 

(b)
Subject to applicable state and federal law, the Company shall at all times have the right, upon written notice to the Employee,
to terminate this Agreement based on the Employee’s Disability (as defined below). Termination by the Company of the Employee’s
employment based on “Disability” shall mean termination because the Employee is unable due to a physical
or mental condition to perform the essential functions of his position with or without reasonable accommodation for six (6) months
in the aggregate during any twelve (12) month period or based on the written certification by two licensed physicians of the likely
continuation of such condition for such period. This definition shall be interpreted and applied consistent with the Americans
with Disabilities Act, the Family and Medical Leave Act, and other applicable law. In the event Employee’s employment is
terminated based on the Employee’s Disability, Employee will not receive severance payments, or any other severance compensation
or benefit, except that, pursuant to the Company’s standard payroll policies, the Company shall pay to Employee the accrued
but unpaid salary of Employee through the date of termination, together with all compensation and benefits payable to Employee
based on his participation in any compensation or benefit plan, program or arrangement through the date of termination.

 

5.6 Notice; Effective
Date of Termination.

 

(a)
Termination of Employee’s employment pursuant to this Agreement shall be effective on the earliest of:

 

(i)
immediately after the Company gives notice to Employee of Employee’s termination, with or without Cause, unless the
Company specifies a later date, in which case, termination shall be effective as of such later date or, if the Company is obligated
under Section 5.2(b) to provide prior notice, thirty (30) days after the Company gives written notice to the Employee of
his termination for Cause unless the Employee has cured the

    	11

    	

    

circumstances
constituting Cause (if curable) on or before that date;

 

(ii) immediately
upon the Employee’s death;

 

(iii)
ten (10) days after the Company gives notice to Employee of Employee’s termination on account of Employee’s Disability,
unless the Company specifies a later date, in which case, termination shall be effective as of such later date, provided that
Employee has not returned to the full time performance of Employee’s duties prior to such date; or

 

(iv)
ten (10) days after the Employee gives written notice to the Company of Employee’s resignation without good reason,
provided that the Company may set a termination date at any time between the date of notice and the date of resignation,
in which case the Employee’s resignation shall be effective as of such other date. Employee will receive compensation through
any required notice period.

 

(v)
thirty (30) days after Employee gives written notice to the Company of Employee’s resignation for Good Reason unless
the Company has cured the circumstances constituting Good Reason on or before that date;

 

(b)
In the event notice of a termination under subsections (a)(i) or (iii) is given orally, at the Employee’s request,
the Company must provide written confirmation of such notice within five (5) business days of the request in compliance with the
requirement of Section 6.1 below. In the event of a termination for Cause, written confirmation shall specify the subsection(s)
of the definition of Cause relied on to support the decision to terminate.

 

5.7
Cooperation With Company After Termination of Employment. Following termination of Employee’s employment for
any reason, Employee shall fully cooperate with the Company in all matters relating to the winding up of Employee’s pending
work including, but not limited to, any litigation in which the Company is involved, and the orderly transfer of any such
pending work to such other Employees as may be designated by the Company.

 

5.8 Change in
Control.

 

(a)
In the event of a Change in Control (as defined below), and provided such transaction is also a “change in the ownership
or effective control of” the Company or “in the ownership of a substantial portion of the assets of” the Company, then
(i) all outstanding unvested equity awards then held by the Employee shall accelerate and vest in full; and (ii) if the Employee
is terminated on or within one (1) year following the Change in Control, then the severance in Section 5.1(b)(i) for which
the Employee will be eligible for upon a termination pursuant to Section 5.1 or 5.4 will be paid in a lump sum on the Sixtieth
(60th) day following the Separation From Service instead of on regular payroll dates during the Severance Period (with
the severance in Section 5.1(b)(ii) paid pursuant to the original schedule in that Section with no acceleration as provided for
herein), and all other provisions of Section 5.1 and 5.4, including without limitation the requirement of an effective Release
to receive any severance benefits remain the same.

    	12

    	

    

(b)
If any payment or benefit Employee would receive pursuant to a Change in Control from the Company or otherwise (the “Payment”)
would (1) constitute a “parachute payment” within the meaning of Section 280G of the Code, and (2) but for this Section,
be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), and (3) immediately
prior to the consummation of the Change of Control, the Company’s stock is not readily tradable on an established securities
market or otherwise and (4) the Employee agrees to waive in a manner that satisfies Section 1.280G-1 of the Treasury Regulations
that portion of the Payment that equals and exceeds three times the Employee’s base amount (as determined in accordance
with Section 1.280G-1 of the Treasury Regulations) (such portion, the “Excess Payment”), the Company
shall use its reasonable best efforts to solicit (in a manner which satisfies all applicable requirements of such Section 280G(b)(5)(B)
of the Code and the Treasury Regulations thereunder, including Q-7 of Section 1.280G-1 of the Treasury Regulations) the vote by
such number of shareholders of the Company as is required by the terms of Section 280G(b)(5)(B) of the Code so as to render the
parachute payment provisions of Sections 280G and 4999 of the Code inapplicable to the Payment. If immediately prior to the consummation
of the Change of Control, the Company’s stock is readily tradable on an established securities market or otherwise, or the
Employee refuses to waive that portion of the Payment that constitutes the Excess Payment, then the Payment shall be equal to
the Reduced Amount. The “Reduced Amount” shall be either (x) the largest portion of the Payment
that would result in no portion of the Payment being subject to the Excise Tax  or (y) the largest portion, up to and including
the total, of the Payment, whichever amount, after taking into account all applicable federal, state and local employment taxes,
income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in Employee’s receipt,
on an after-tax basis, of the greater economic benefit notwithstanding that all or some portion of the Payment may be subject
to the Excise Tax. If a Reduced Amount will give rise to the greater after tax benefit, the reduction in the Payments shall occur
in the following order: (i) reduction of cash payments; (ii) cancellation of accelerated vesting of equity awards other
than stock options; (iii) cancellation of accelerated vesting of stock options; and (iv) reduction of other benefits paid to
Employee. Within any such category of payments and benefits (that is, (i), (ii), (iii) or (iv)), a reduction shall occur first
with respect to amounts that are not “deferred compensation” within the meaning of Code Section 409A and then with
respect to amounts that are. In the event that acceleration of compensation from Employee’s equity awards is to be reduced,
such acceleration of vesting shall be canceled, subject to the immediately preceding sentence, in the reverse order of the date
of grant.

 

(i)
In the event it is subsequently determined by the Internal Revenue Service that some portion of the Reduced Amount as determined
pursuant to clause (x) in the preceding paragraph is subject to the Excise Tax, Employee agrees to promptly return to the Company
a sufficient amount of the Payment so that no portion of the Reduced Amount is subject to the Excise Tax. For the avoidance of
doubt, if the Reduced Amount is determined pursuant to clause (y) in the preceding paragraph. Employee will have no obligation
to return any portion of the Payment pursuant to the preceding sentence.

 

(ii)
Unless Employee and the Company agree on an alternative accounting firm, the accounting firm engaged by the Company for general
tax compliance purposes as of the day prior to the effective date of the Change in Control shall perform the foregoing calculations.
If the accounting firm so engaged by the Company is serving as

    	13

    	

    

accountant
or auditor for the individual, entity or group effecting the Change in Control, the Company shall appoint a nationally recognized
accounting firm to make the determinations required hereunder. The Company shall bear all expenses with respect to the determinations
by such accounting firm required to be made hereunder.

 

(iii)
The Company shall use commercially reasonable efforts to cause the accounting firm engaged to make the determinations hereunder
to provide its calculations, together with detailed supporting documentation, to Employee and the Company within fifteen (15)
calendar days after the date on which Employee’s right to a Payment is triggered (if requested at that time by Employee
or the Company) or such other time as reasonably requested by Employee or the Company.

 

(c)
“Change in Control” means the occurrence, in a single transaction or in a series of related
transactions, of any one or more of the following events:

 

(i)
any person, entity or group (within the meaning of the Securities Exchange Act of 1934, as amended) (such person, entity, or group,
an “Exchange Act Person”), becomes the owner, directly or indirectly, of securities of the Company
representing more than fifty percent (50%) of the combined voting power of the Company’s then outstanding securities other
than by virtue of a merger, consolidation or similar transaction;

 

(ii)
there is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately
after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior
thereto do not own, directly or indirectly, either (A) outstanding voting securities representing more than fifty percent (50%)
of the combined outstanding voting power of the surviving Entity in such merger, consolidation or similar transaction or (B) more
than fifty percent (50%) of the combined outstanding voting power of the parent of the surviving entity in such merger, consolidation
or similar transaction; or

 

(iii)
there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets
of the Company and its subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the
consolidated assets of the Company and its subsidiaries to an entity, more than fifty percent (50%) of the combined voting power
of the voting securities of which are owned by stockholders of the Company in substantially the same proportions as their ownership
of the outstanding voting securities of the Company immediately prior to such sale, lease, license or other disposition.

 

Notwithstanding
the foregoing, the term Change in Control shall not include a sale of assets, merger or other transaction effected exclusively
for the purpose of changing the domicile of the Company.

 

5.9
Application of Section 409A. Notwithstanding anything to the contrary set forth herein, to the extent that any payments
and benefits provided under this Agreement constitute “deferred compensation” within the meaning of Section 409A of
the Internal Revenue Code of 1986, as amended (“Code”) and the regulations and other guidance thereunder
and any

    	14

    	

    

state
law of similar effect (collectively, “Section 409A”), such payments and benefits shall not commence
in connection with Employee’s termination of employment unless and until Employee has also incurred a “separation
from service” (as such term is defined in Treasury Regulation Section 1.409A-1(h), without reference to alternative definitions
thereunder, a (“Separation From Service”), unless the Company reasonably determines that a Separation
From Service is not a necessary precondition to payment and as a result such amounts may be provided to Employee without causing
Employee to incur the additional 20% tax under Section 409A. It is intended that each installment of severance pay and benefits
provided for in this Agreement is a separate “payment” for purposes of Treasury Regulation Section 1.409A-2(b)(2)(i).
For the avoidance of doubt, it is intended that severance payments set forth in this Agreement satisfy, to the greatest extent
possible, the exceptions from the application of Section 409A provided under Treasury Regulation Sections 1.409A-l(b)(4), 1.409A-l(b)(5),
and 1.409A-1(b)(9). If the Company (or, if applicable, the successor entity thereto) determines that any payments or benefits
constitute “deferred compensation” under Section 409A and Employee is, on the termination of service, a “specified
employee” of the Company or any successor entity thereto, as such term is defined in Section 409A(a)(2)(B)(i) of the Code,
then, solely to the extent necessary to avoid the incurrence of the adverse personal tax consequences under Section 409A, the
timing of the payments and benefits shall be delayed until the earliest to occur of: (a) the date that is six months and one day
after Employee’s Separation From Service, (b) the date of Employee’s death or (c) such earlier date as is permitted
under Section 409A (such applicable date, the “Specified Employee Initial Payment Date”). On
the Specified Employee Initial Payment Date, the Company (or the successor entity thereto, as applicable) shall (i) pay to Employee
a lump sum amount equal to the sum of the payments and benefits that Employee would otherwise have received through the Specified
Employee Initial Payment Date if the commencement of the payment of such amounts had not been so delayed pursuant to this Section
and (ii) commence paying the balance of the payments and benefits in accordance with the applicable payment schedules set forth
in this Agreement.

 

6.
General Provisions.

 

6.1
Notices. Any notices required hereunder to be in writing shall be deemed effectively given: (a) upon personal delivery
to the party to be notified, (b) when sent by electronic mail, telex or confirmed facsimile if sent during normal business hours
of the recipient, and if not, then on the next business day, (c) five (5) days after having been sent by registered or certified
mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight courier,
specifying next day delivery, with written verification of receipt. All communications shall be sent to the Company at its primary
office location and to Employee at Employee’s address as listed on the Company payroll, or at such other address as the
Company or the Employee may designate by ten (10) days advance written notice to the other.

 

6.2
Severability. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any
respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect
any other provision or any other jurisdiction, but this Agreement will be reformed,

    	15

    	

    

construed
and enforced in such jurisdiction as if such invalid, illegal or unenforceable provisions had never been contained herein.

 

6.3
Waiver. If either party should waive any breach of any provisions of this Agreement, Employee or it shall not thereby
be deemed to have waived any preceding or succeeding breach of the same or any other provision of this Agreement.

 

6.4
Complete Agreement. This Agreement constitutes the entire agreement between Employee and the Company with regard to
the subject matter hereof. This Agreement is the complete, final, and exclusive embodiment of their agreement with regard to this
subject matter and supersedes any prior oral discussions or written communications and agreements. This Agreement is entered into
without reliance on any promise or representation other than those expressly contained herein, and it cannot be modified or amended
except in writing signed by Employee and an authorized officer of the Company. The parties have entered into separate stock option
agreements and have or may enter into separate agreement related to stock option and/or other equity awards. These separate agreements
govern other aspects of the relationship between the parties, have or may have provisions that survive termination of the Employee’s
employment under this Agreement, may be amended or superseded by the parties without regard to this agreement and are enforceable
according to their terms without regard to the enforcement provision of this Agreement.

 

6.5
Counterparts. This Agreement may be executed in separate counterparts, any one of which need not contain signatures
of more than one party, but all of which taken together will constitute one and the same Agreement.

 

6.6
Headings. The headings of the sections hereof are inserted for convenience only and shall not be deemed to constitute
a part hereof nor to affect the meaning thereof.

 

6.7 Successors
and Assigns. The Company shall assign this Agreement and its rights and obligations hereunder in whole, but not in
part, to any Company or other entity with or into which the Company may hereafter merge or consolidate or to which the
Company may transfer all or substantially all of its assets, if in any such case said Company or other entity shall by
operation of law or expressly in writing assume all obligations of the Company hereunder as fully as if it had been
originally made a party hereto, but may not otherwise assign this Agreement or its rights and obligations hereunder. The
Employee may not assign or transfer this Agreement or any rights or obligations hereunder, other than to his estate
upon his death.

 

6.8
Choice of Law. All questions concerning the construction, validity and interpretation of this Agreement will be governed
by the law of the State of Delaware. The parties agree that any litigation permitted under this Agreement, included but not limited
to litigation pursuant to Section 3 and enforcement of any arbitration award shall be brought in a state or federal court sitting
in Delaware.

 

6.9
Resolution of Disputes. The parties recognize that litigation in federal or state courts or before federal or state
administrative agencies of disputes arising out of the Employee’s employment with the Company or out of this Agreement,
or the Employee’s

    	16

    	

    

termination
of employment or termination of this Agreement, may not be in the best interests of either the Employee or the Company, and may
result in unnecessary costs, delays, complexities, and uncertainty. The parties agree that any dispute between the parties arising
out of or relating to the negotiation, execution, performance or termination of this Agreement or the Employee’s employment,
including, but not limited to, any claim arising out of this Agreement, claims under Title VII of the Civil Rights Act of 1964,
as amended, the Civil Rights Act of 1991, the Age Discrimination in Employment Act of 1967, the Americans with Disabilities Act
of 1990, Section 1981 of the Civil Rights Act of 1966, as amended, the Family Medical Leave Act, the Employee Retirement Income
Security Act, and any similar federal, state or local law, statute, regulation, or any common law doctrine, whether that dispute
arises during or after employment, shall be settled by binding arbitration in accordance with the National Rules for the Resolution
of Employment Disputes of the American Arbitration Association; provided however, that this dispute resolution provision
shall not apply to Section 3 of this Agreement nor to any separate agreements between the parties that do not themselves specify
arbitration as an exclusive remedy. The location for the arbitration shall be the New York, New York metropolitan area.
Any award made by such panel shall be final, binding and conclusive on the parties for all purposes, and judgment upon the award
rendered by the arbitrators may be entered in any court having jurisdiction thereof. The arbitrators’ fees and expenses
and all administrative fees and expenses associated with the filing of the arbitration shall be borne equally by the parties unless
applicable law requires otherwise. The parties acknowledge and agree that their obligations to arbitrate under this Section survive
the termination of this Agreement and continue after the termination of the employment relationship between Employee and the Company.
The parties each further agree that the arbitration provisions of this Agreement shall provide each party with its exclusive
remedy, and each party expressly waives any right it might have to seek redress in any other forum, except as otherwise expressly
provided in this Agreement. By election arbitration as the means for final settlement of all claims, the parties hereby waive
their respective rights to, and agree not to, sue each other in any action in a Federal, State or local court with respect to
such claims, but may seek to enforce in court an arbitration award rendered pursuant to this Agreement. The parties specifically
agree to waive their respective rights to a trial by jury, and further agree that no demand, request or motion will be made for
trial by jury.

 

In
Witness Whereof, the parties have executed this Employment Agreement on the day and year first written above.

 

	Everyday Health, Inc.:	 	Employee:
	 	 	 
	By:	/s/ Alan Shapiro	 	/s/ Michael Keriakos
	 	Name: Alan Shapiro	 	Michael Keriakos
	 	Title: EVP & General Counsel	 	 

    	17Exhibit 10.8.1

 

December 19, 2013

 

Mike Keriakos

88 Laight Street, #3

New York City, NY 10013-2070

 

Dear Mike:

While
the Everyday Health, Inc. (“Company”) management team, Board of Directors (“Board”) and (most especially)
I will miss your involvement in day-to-day operations and strategic vision, we understand your
desire to put in place a transition plan in anticipation of the Company’s initial public offering. As you prepare for your
next endeavors, it is with tremendous gratitude for your friendship, service and leadership that I am pleased to set forth below
the terms of this important transition. These terms are referred to herein as the “Agreement.”

 

Certain capitalized terms used but not otherwise
defined in this Agreement are defined in Annex A.

 

1.
Separation Date. We have agreed with you that your last day of employment with the Company and your employment termination
date will be December 31, 2013 (the “Separation Date”). At 11:59 p.m. on the Separation Date, that certain Employment
Agreement entered into between you and the Company on or about November 22, 2010 (the “Employment Agreement”)1
will terminate with no further force or effect.

 

2.
Transition Period and Duties. Beginning January 1, 2014 and continuing through and including December 31, 2015 (the
“Advisory Period”), you have agreed to provide advisory and transition services to the Company. During this period,
you will serve under the title of Co-Founder and Leader of the Company’s Board of Advisors. In addition to carrying out

 

 

    	 

    	

    

your duties on
the Board of Advisors, it is anticipated that you will also keep the Company abreast of important trends and developments identified
by you among start-up digital health information and related companies, as well as among related business incubator programs with
which you have relationships that are focused on digital health information and related companies. You will also provide such advisory
services and consultation as the Chief Executive Officer of the Company and you may reasonably agree from time to time during the
Advisory Period. During the Advisory Period, in light of the change in your role, you will no longer have, and will not represent
that you have, legal authority to act on behalf of or to bind the Company. You understand and agree that the services you provide
during the Advisory Period shall not operate to create a contract of employment with the Company. Such services will be provided
by you as an independent contractor to the Company. During the Advisory Period, your current office space will continue to be available
to you, as well as the general administrative services of the office. Following the Separation Date, however, in light of the change
in your role, you will not have a dedicated administrative assistant beyond January 31, 2014 or other dedicated services.

    	2

    	

3.
Board Service. Although you have agreed to remain on the Board following the Separation Date as part of the transition,
you and the Company have agreed that immediately upon a Change in Control, or upon the effective date of the registration statement
relating to the Company’s initial public offering, you will be deemed to have resigned from the Board of Directors. If necessary,
you and the Company will promptly execute any documents required to memorialize your resignation.

 

4.
Compensation and Advisory Service Fee Matters.

 

(a)
Accrued Salary. On or before the first regularly scheduled payroll date following the Separation Date, the Company
will pay you all accrued salary earned through the Separation Date, subject to standard payroll deductions and required withholdings.

 

(b) Transition
Payment. The Company will pay you, as part of the transition, the gross amount of Seven Hundred and Fifty Thousand
Dollars ($750,000.00), subject to required withholdings. This amount will be paid over a period of 12 months in equal installments
on the Company’s regularly scheduled payroll dates beginning with the first such payroll date following the Separation Date.

 

(c)
Advisory Services Fee. The Company will pay you a fee in the amount of Six Hundred and Fifty Thousand Dollars ($650,000.00)
as additional consideration hereunder. This amount will be paid as follows: (1) Four Hundred and Fifty Thousand Dollars ($450,000.00)
on April 1, 2014; and (2) Two Hundred Thousand Dollars ($200,000.00) on April 1, 2015. This fee shall not be subject to withholdings
and will be reported by the Company to the IRS via Form 1099. You understand and agree that you will be responsible for all taxes
associated with such fee.

    	3

    	

5.
Stock Options. Annex B sets forth all outstanding options granted to you under the Company’s 2003 Stock Option Plan
(the “Plan”). All unvested options held by you, including the option granted to you for 56,250 shares pursuant to
the Action by Unanimous Written Consent of the Compensation Committee of Everyday Health, Inc. dated June 11, 2013 (the “Unanimous
Consent”), shall vest in full on the Separation Date, and the Compensation Committee shall take all action prior to the
Separation Date to effect such accelerated vesting, including in the case of the grant made under the Unanimous Consent, taking
action such that said option shall no longer vest contingent upon the event(s) as set forth in the Unanimous Consent but instead
shall vest in full on the Separation Date. As part of this Agreement, the Company shall permit you (or in the event of your death
or disability, your heirs, executors and legal representatives, as applicable) to exercise any or all of your options on or before
December 31, 2017, and the Compensation Committee shall take all action prior to the Separation Date to effect such permitted
exercise. Except as stated herein, your options shall be subject to the terms of the Plan and grant documents, copies of each
of which have been provided to your counsel; provided that you shall not be obligated to enter into any “lock-up”
agreement other than a “lock-up” agreement in connection with an underwritten initial public offering by the Company,
in form and substance substantially identical to those entered into by the Company’s other stockholders and optionholders;
and further provided that you hereby acknowledge and agree to remain bound by your existing obligations pursuant to that certain
“lock-up” agreement executed by you in favor of J.P. Morgan Securities LLC, as representative of the several underwriters,
in connection with the Company’s currently contemplated initial public offering (the “Lock-Up”) and hereby further
agree that the automatic termination date of the Lockup in the event that the Underwriting Agreement (as defined in the Lock-Up)
is not executed by March 31, 2014 shall be

    	4

    	

extended to the
same date as the “lock-up” agreements entered into by the Company’s other stockholders and optionholders.

 

6.
Health Benefits. To the extent provided by the federal COBRA law or,
if applicable, state insurance laws (collectively, “COBRA”), and by the Company’s current group health insurance
policies, you may be eligible to continue your group health insurance benefits after the Separation Date at your own expense.
Later, you may be able to convert to an individual policy through the provider of the Company’s health insurance, if you
wish. Within the timing required by law, you will be provided with a separate notice describing your rights and obligations with
respect to continued group health insurance coverage under the applicable state and/or federal insurance laws. For the 18-month
period following the Separation Date, the Company shall pay to you, on the first day of each month, a fully taxable cash payment
equal to the applicable COBRA premiums for that month (including premiums for you and your eligible dependents), subject to applicable
tax withholdings (such amount, the “Special Cash Payment”). You may, but are not obligated to, use such Special
Cash Payment toward the cost of COBRA premiums The Company shall pay to you the Special Cash Payment on the first day of each
month, beginning January 1, 2014.

 

7.
No Other Compensation or Benefits. You acknowledge that, except as expressly provided in this Agreement, the Company
is not obligated to provide you with any additional compensation, severance, or benefits after the Separation Date. Specifically,
you understand and agree that the compensation and benefits provided to you in this Agreement are in lieu of and not in addition
to any other compensation or benefit to which you may otherwise be entitled to, including, but not limited to, the compensation
and benefits provided for in the Employment Agreement.

    	5

    	

8.
Expense Reimbursements. You agree that, within sixty (60) days of the Separation Date, you will submit any final
documented expenses incurred through the Separation Date, if any, for which you seek reimbursement. The Company will reimburse
you for these expenses pursuant to its regular business practice. The Company will reimburse reasonable expenses incurred in connection
with your duties during the Advisory Period pursuant to its regular business practice. The Company will reimburse you $12,500
for the legal fees and expenses incurred by you in connection with the negotiation, preparation, interpretation, and execution
of this Agreement and shall be paid by the Company no later than the Separation Date.

 

9.
Return of Company Property. By January 8, 2016, unless requested earlier by the Company, you agree to use commercially
reasonable efforts to: (i) return to the Company all (x) tangible Company documents (and all tangible copies thereof) and other
tangible Company property that you have in your possession, including, but not limited to, Company files, notes, drawings, records,
business plans and forecasts, financial information, specifications, physical property (including, but not limited to, computers),
credit cards, entry cards, identification badges, and keys; and, any (y) tangible materials of any kind that contain or embody
any proprietary or confidential information of the Company (and all tangible reproductions thereof) and (ii) delete computer files
embodying the foregoing proprietary or confidential information of the Company so as not to be readily accessible to an end user.

 

10. Confidential
Information Obligations and Restrictive Covenants.

 

(a)
You understand and agree that, after the Separation Date and during and after the Advisory Period, you shall hold in strict
confidence and shall not disclose, directly or indirectly, to any third party, person, firm, corporation or other entity, irrespective
of whether

    	6

    	

    

such person or
entity is a competitor of the Company or is engaged in a business similar to that of the Company, any Confidential Information
of the Company or any subsidiary or controlled Affiliate of the Company obtained or developed by you from, through, or in the course
of your employment with the Company or your services hereunder.

 

(b)
Notwithstanding the foregoing limitations, you shall not be required to keep confidential any information that: (i) is known
or available through other lawful sources, or (ii) is or becomes publicly available or generally known in the industry through
no fault of yours, your agents or another individual or entity that owes a duty of confidentiality to the Company, or (iii) is
required to be disclosed pursuant to any statutes, laws, rules, regulations, ordinances, codes, directives, writs, injunctions,
decrees, judgments, and orders of any governmental body (provided the Company is given reasonable prior notice).

 

(c)
Nothwithstanding anything in this Agreement to the contrary, you understand and agree that the assignment of inventions provided
for in Section 3.4 of the Employment Agreement (“Assignment and Disclosure of Inventions”) remains effective. You also
agree to continue to cooperate with the Company, at the Company’s sole cost and expense, both during and after employment and
after your services under this Agreement, with respect to the procurement, maintenance and enforcement of copyrights, patents
and other intellectual property rights (both in the United States and foreign countries) relating to assigned inventions. This
includes signing all papers, including, without limitation, copyright applications, patent applications, declarations, oaths,
formal assignments, assignments of priority rights, and powers of attorney, which are reasonably necessary in order to protect
its rights and interests. You further agree that if the Company is unable, after reasonable effort, to secure your signature on
any such papers, any officer of the Company shall be entitled to execute any such papers as your

    	7

    	

    

agent
and attorney-in-fact, and you hereby irrevocably designate and appoint each officer of the Company as your agent and attorney-in-fact
to execute any such papers on your behalf, and to take any and all actions which may be reasonably necessary to protect the Company’s
rights and interests in any assigned invention.

 

(d)
You further understand and agree that through the Advisory Period, you will not, as an officer, director, employee, consultant,
owner, partner, or in any other capacity, either directly or through others, without the written approval of the Company:

 

(1) perform work
for a business that provides Conflicting Services (or in the case of clauses (iv) and (v) of the definition thereof, perform the
work prohibited thereby);

 

(2) request, induce,
or attempt to induce any Customer or Potential Customer to terminate or reduce its relationship with the Company or any subsidiary
or controlled Affiliate of the Company;

 

(3) interfere with
or disrupt, or attempt to interfere with or disrupt, the relationship, contractual or otherwise, between the Company, or any subsidiary
or controlled Affiliate of the Company, and any customer, vendor, licensor, supplier or employee of the Company or any subsidiary
or controlled Affiliate of the Company;

 

(4) offer employment
to any person who is a then current employee of the Company or any subsidiary or controlled Affiliate of the Company or has left
the Company or any subsidiary or controlled Affiliate of the Company in the preceding three (3) months; or

 

(5) solicit (directly
or indirectly, individually or in connection with any new employer or other business partner) any person who is a then current
employee of the Company

    	8

    	

    

or any subsidiary or controlled Affiliate
of the Company or has left the Company or any subsidiary or Affiliate in the preceding three (3) months to accept employment elsewhere;
provided, however, that general solicitations of employment not specifically directed toward employees of the Company or its subsidiaries
or controlled Affiliates are permitted and will not violate this clause (5), or, provided such person is not employed, violate
clause (4) above.

 

11.
Confidentiality. The provisions of this Agreement will be held in strictest confidence by you and the Company and will
not be publicized or disclosed in any manner whatsoever; provided, however, that: (a) you may disclose this Agreement in
confidence to your immediate family, prospective employers and business partners, and financing sources; (b) the parties may
disclose this Agreement in confidence to their respective attorneys, accountants, auditors, tax preparers, and financial
advisors; (c) the Company may disclose this Agreement as necessary to fulfill standard or legally required corporate
reporting or disclosure requirements, including but not limited to, Securities and Exchange Commission filings; (d) the
Company may disclose this Agreement on the same basis as if disclosing other confidential information as part of bona fide
financing, merger and acquisition, Change in Control, initial public offering or similar activity; and (e) the parties may
disclose this Agreement insofar as such disclosure may be necessary to enforce its terms or as otherwise required by law. The
Company and you will mutually agree on all public statements and communications to Company stakeholders regarding the matters
contemplated hereby.

 

12. Non-disparagement.
The Company shall instruct its officers and directors not to disparage you in any manner or through any medium likely to be
harmful to you or your business, business reputation or your personal reputation. You agree not to disparage the Company and
its officers and directors, in any manner or through any medium likely to be

    	9

    	

    

harmful to them or their business or
business reputation each as related to the Company and its subsidiaries. In the event that either party violates the non-disparagement
obligation (or, in the case of the Company, any of its officers or directors fail to abide by the above instruction), the other
party shall be permitted to respond as they reasonably believe appropriate under the circumstances without being limited by the
above restrictions. The foregoing notwithstanding, both you and the Company shall respond accurately and fully to any inquiry in
the course of a government investigation or as required by compulsion of law (including as required by a subpoena).

 

13. No
Admissions. You understand and agree that the promises and payments in consideration of this Agreement shall not
be construed to be an admission of any liability by the Company to you or to any other person, and that the Company makes no
such admission.

 

14.
Release of Claims. In exchange for the mutual release provided for in this Section 14, except as provided herein,
you hereby generally and completely release the Company and its directors, officers, employees, shareholders, partners, agents,
attorneys, predecessors, successors, parent and subsidiary entities, affiliates, and assigns from any and all claims, liabilities
and obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct or omissions occurring
with respect to your relationship with the Company at any time prior to and including the date you sign this Agreement. This general
release includes, but is not limited to claims under: Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights
Act of 1991; Sections 1981 through 1988 of Title 42 of the United States Code, as amended; the Employee Retirement Income Security
Act of 1974, as amended; the Americans with Disabilities Act of 1990, as amended; the Age Discrimination in Employment Act of
1967, as amended (“ADEA”); New York Human Rights Laws, as amended;

    	10

    	

    

the New
York Civil Rights Act, as amended; the New York Minimum Wage Law, as amended; Equal Pay Law for New York, as amended; any other
federal, state or local civil or human rights law or any other local, state or federal law, regulation or ordinance; and any public
policy, contract, tort, or common law. The foregoing release does not encompass, and you do not release: (i) any and all claims
or rights that you may have with respect to your capacity as a stockholder or optionholder of the Company, including under any
stockholder agreement, option plan or option grant documents and similar instruments; (ii) claims and rights to indemnification,
contribution or insurance arising from your service as an employee, officer, director, stockholder or optionholder of the Company;
or (iii) your rights under this Agreement.

 

In
exchange for the mutual release provided for in this Section 14, except as provided herein, the Company on behalf of itself and
its directors, officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, parent and subsidiary
entities, affiliates, and assigns hereby generally and completely release you and your family members, affiliates, successors
and assigns from any and all claims, liabilities and obligations, both known and unknown, that arise out of or are in any way
related to events, acts, conduct or omissions occurring with respect to your relationship with the Company or service as an officer
or director of the Company, at any time prior to and including the date you sign this Agreement. This general release includes,
but is not limited to claims under: Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1991; Sections
1981 through 1988 of Title 42 of the United States Code, as amended; the Employee Retirement Income Security Act of 1974, as amended;
the Americans with Disabilities Act of 1990, as amended; the Age Discrimination in Employment Act of 1967, as amended (“ADEA”);
New York Human Rights Laws, as amended; the New York Civil Rights Act, as amended; the New York Minimum Wage Law, as amended;

    	11

    	

    

Equal Pay
Law for New York, as amended; any other federal, state or local civil or human rights law or any other local, state or federal
law, regulation or ordinance; and any public policy, contract, tort, or common law. The foregoing release does not encompass, and
the Company does not release its rights under this Agreement.

 

15.
Indemnification. You shall be entitled to the benefits of all provisions of the Certificate of Incorporation of the Company,
as amended, and the Bylaws of the Company, as amended, that provide for indemnification, exculpation, contribution and reimbursement
of officers, directors and/or employees of the Company. In addition, without limiting such provisions of the Certificate of Incorporation
or Bylaws, or any other agreement with the Company, to the fullest extent permitted by law, the Company shall indemnify you and
save and hold you harmless from and against, and pay or reimburse, any and all claims, demands, liabilities, costs and expenses,
including judgments, fines or amounts paid on account thereof (whether in settlement or otherwise), and reasonable expenses, including
attorneys’ fees actually and reasonably incurred, if you are made a party to or witness in any action, suit or proceeding,
or if a claim or liability is asserted against you (whether or not in the right of the Company), by reason of the fact that you
are or were a director, officer, employee, consultant, advisor or acted in such capacity on behalf of the Company, or the rendering
of services by you pursuant to this Agreement or any of your prior employment agreements with the Company (including the Employment
Agreement), whether or not the same shall proceed to judgment or be settled or otherwise brought to a conclusion. Upon your request,
the Company will advance any reasonable expenses or costs, subject to your undertaking to repay any such advances in the event
there is an unappealable final determination that you are not entitled to indemnification for such expenses. This provision shall
survive the expiration or termination of this Agreement.

    	12

    	

    

16.
Termination.

 

(a)
Subject to subsection (b) below, this Agreement may not be terminated in whole or in part by the Company, and all rights and
benefits provided to you hereunder, including under Sections 4, 5, 6 and 8 shall in all events be timely paid and furnished to
you (or in the event of your death or disability, your heirs, executors and legal representatives, as applicable).

 

(b)
Notwithstanding the foregoing, the Company may provide you with written notice of your alleged material breach of the provisions
of Section 10 within 30 days of an officer of the Company first becoming aware of facts that would constitute an alleged breach,
setting forth with reasonable specificity the conduct alleged to constitute such breach (it being agreed that the Company’s
failure to timely provide such notice shall be deemed to constitute a waiver of the alleged breach in question). You shall then
have a period of 30 days to either take reasonable steps to remedy the alleged breach or object to the notice of breach in writing.
In the event you take reasonable steps to remedy the alleged breach, if such breach is subject to remedy such that the Company
does not suffer material injury or harm as a result of the breach, then you shall have no further liability hereunder in connection
therewith.

 

17.
Application of Section 409A. Notwithstanding anything to the contrary set forth herein, to the extent that any payments
and benefits provided under this Agreement constitute “deferred compensation” within the meaning of Section 409A of
the Internal Revenue Code of 1986, as amended (“Code”) and the regulations and other guidance thereunder and any state
law of similar effect (collectively, “Section 409A”), such payments and benefits shall not commence in connection
with your termination of employment unless and until you have also incurred a

    	13

    	

    

“separation
from service” (as such term is defined in Treasury Regulation Section 1.409A-l(h), without reference to alternative definitions
thereunder, a “Separation From Service”), unless the Company reasonably determines that a Separation From Service is
not a necessary precondition to payment and as a result such amounts may be provided to you without causing you to incur the additional
20% tax under Section 409 A. For the sake of clarity, it is intended that you incur a Separation From Service on the Separation
Date, and the parties acknowledge that the amount of the advisory and transition services to be provided during the Advisory Period
shall be at a level that is not greater than (and may be less than) 20% of the average level of services you provided over the
thirty-six (36) months immediately preceding the Advisory Period.

 

It
is intended that each installment of severance pay and benefits provided for in this Agreement is a separate “payment”
for purposes of Treasury Regulation Section 1.409A-2(b)(2)(i). For the avoidance of doubt, it is intended that severance payments
set forth in this Agreement satisfy, to the greatest extent possible, the exceptions from the application of Section 409A provided
under Treasury Regulation Sections 1.409A-l(b)(4), 1.409A-l(b)(5), and 1.409A-l(b)(9). If the Company (or, if applicable, the
successor entity thereto) determines that any payments or benefits constitute “deferred compensation” under Section
409A and you are, upon your Separation From Service, a “specified employee” of the Company or any successor entity
thereto, as such term is defined in Section 409A(a)(2)(B)(i) of the Code, then, solely to the extent necessary to avoid the incurrence
of the adverse personal tax consequences under Section 409A, the timing of the payments and benefits shall be delayed until the
earliest to occur of: (a) the date that is six months and one day after your Separation From Service, (b) the date of your death
or (c) such earlier date as is permitted under Section 409A (such applicable date, the “Specified Employee Initial Payment
Date”). On the Specified Employee Initial Payment Date,

    	14

    	

    

the Company
(or the successor entity thereto, as applicable) shall (i) pay to you a lump sum amount equal to the sum of the payments and benefits
that you would otherwise have received through the Specified Employee Initial Payment Date if the commencement of the payment of
such amounts had not been so delayed pursuant to this Section and (ii) commence paying the balance of the payments and benefits
in accordance with the applicable payment schedules set forth in this Agreement. To the extent any indemnification payment, expense
reimbursement, or the provision of any in-kind benefit is determined to be subject to Section 409A (and not exempt pursuant to
Treasury Regulation § 1.409A-l(b)(9)(v)(A) or (C) or otherwise), the amount of any such indemnification payment or expenses
eligible for reimbursement, or the provision of any in-kind benefit, in one calendar year shall not affect the indemnification
payment or provision of in-kind benefits or expenses eligible for reimbursement in any other calendar year (except for any life-time
or other aggregate limitation applicable to medical expenses), and in no event shall any indemnification payment or expenses be
reimbursed after the last day of the calendar year following the calendar year in which you incurred such indemnification payment
or expenses, and in no event shall any right to indemnification payment or reimbursement or the provision of any in-kind benefit
be subject to liquidation or exchange for another benefit.

 

18.
General Provisions. This Agreement, including the Exhibits and Annexes
hereto, constitutes the complete, final and exclusive embodiment of the entire
agreement between you and the Company with regard to its subject matter. It is
entered into without reliance on any promise or representation, written or oral,
other than those expressly contained herein, and it supersedes any other such
promises, warranties or representations. This Agreement may not be modified or
amended except in a writing signed by both you and a duly authorized officer
of the Company. This Agreement will bind the heirs, personal representatives,

    	15

    	

    

successors and assigns
of both you and the Company, and inure to the benefit of both you and the Company, their heirs, successors and assigns. If any
provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination will not affect
any other provision of this Agreement and the provision in question will be modified so as to be rendered enforceable. This Agreement
will be deemed to have been entered into and will be construed and enforced in accordance with the laws of the State of New York
as applied to contracts made and to be performed entirely within New York. Any dispute arising out of this Agreement shall be brought
in the state or federal courts of the State of New York, which shall serve as the exclusive forum for any such dispute. Any ambiguity
in this Agreement shall not be construed against either party as the drafter. Any waiver of a breach of this Agreement shall be
in writing and shall not be deemed to be a waiver of any successive breach. This Agreement may be executed in counterparts and
facsimile signatures will suffice as original signatures.

 

If this Agreement is acceptable to you,
please sign below and return the original to me.

 

We wish you the best in your future endeavors.

 

Sincerely,

 

Everyday
Health, Inc.

 

	By:	/s/ Ben Wolin	 
	 	Name: Ben Wolin	 
	 	Title: Chief Executive Officer	 

 

I have read, understand and agree fully
to the foregoing Agreement:

 

/s/ Mike Keriakos

 

Mike Keriakos

 

Date: December 19, 2013

    	16

    	

    

Annex
A

 

Defined Terms.
The following terms shall have the meanings set forth below:

 

(a)
“Affiliate” means any person, firm or corporation, directly or indirectly
through one or more intermediaries, controlling, controlled by or under common control with the Company.

 

(b) “Change
in Control” means the occurrence, in a single transaction or in a series of related transactions, of any one
or more of the following events:

 

(i) any person, entity or group (within
the meaning of the Securities Exchange Act of 1934, as amended) (such person, entity, or group, an “Exchange Act Person”),
becomes the owner, directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the combined
voting power of the Company’s then outstanding securities other than by virtue of a merger, consolidation or similar transaction;

 

(ii) there
is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately after
the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto
do not own, directly or indirectly, either (A) outstanding voting securities representing more than fifty percent (50%) of the
combined outstanding voting power of the surviving Entity in such merger, consolidation or similar transaction or (B) more than
fifty percent (50%) of the combined outstanding voting power of the parent of the surviving entity in such merger, consolidation
or similar transaction; or

 

(iii) there
is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of
the Company and its subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated
assets of the Company and its subsidiaries to an entity, more than fifty percent (50%) of the combined voting power of the voting
securities of which are owned by stockholders of the Company in substantially the same proportions as their ownership of the outstanding
voting securities of the Company immediately prior to such sale, lease, license or other disposition.

 

Notwithstanding the
foregoing, the term Change in Control shall not include a sale of assets, merger or other transaction effected exclusively for
the purpose of changing the domicile of the Company.

 

(c) “Confidential
Information” means any information used by or belonging or related to the Company or any of its
controlled affiliates that is not known generally to the industry in which the Company is or may be engaged and which the
Company maintains on a confidential basis including without limitation any and all intellectual property,

    	A-1

    	

    

trade
secrets and proprietary information, information relating to the Company’s business and services, employee information,
customer lists and records, business processes, procedures or standards, know-how, technology, business strategies, records, financial
information, in each case whether or not reduced to writing or stored electronically, as well as any information that the Company
advises you should be treated as confidential information (including information conceived, discovered or developed by you), that
you learn of, possess, or have access through your employment by the Company or your services under this Agreement, related to
the Company, its business partners, or the business of its Customers or Potential Customers. Confidential Information shall not
include information known to you prior to your employment with the Company. Confidential Information shall not include Company
information which is or becomes Publicly Known through no breach of this Agreement or other act or omission of yours. The burden
of proving that information or skills and experience are not Confidential Information shall be on the party asserting such exclusion.

 

(d) Businesses that provide “Conflicting Services”
are those that:

 

		(i)	Operate a paid or unpaid subscription service/site that provides diet, fitness or health-related information to U.S. consumers
via the Internet, mobile application or other digital platform if such subscription service/site was either (i) operated by the
Company at some point or (ii) after reasonable inquiry you learn that the Company held discussions with a third party about operating
such subscription service/site and the Company has not declined the opportunity to operate such subscription/service/site (it being
agreed that such a service/site based on Pastor Rick Warren’s “The Daniel Plan” or other projects of Saddleback Ministries
shall not constitute Conflicting Services).
		(ii)	Provide a digital service that enables employers, providers, health plans and other risk-bearing entities to better manage
the health and wellness of their U.S.-based patient populations by providing such patient population diet, fitness or health-related
information or health assessments tools and (i) the revenues from such digital service (but excluding any related hardware and
device revenues) during the twelve calendar month period prior to your involvement was more than $10 million and (ii) the revenue
model for such digital service is a license fee based on the number of covered lives participating in the digital service (it being
agreed that Fitbit, Jawbone and similar businesses that primarily focus on selling wearable tracking devices to consumers shall
not constitute Conflicting Services).
		(iii)	Operate a service/site that provides medical or health-related information targeted at U.S. or non-U.S. healthcare professionals
via the Internet, mobile application or other digital platform and the revenue model for such service/site is the sale of advertising
or sponsorships to entities marketing pharmaceutical or medical device products and services or the receipt of CME grants.

    	A-2

    	

    

		(iv)	Had either (i) over $20 million in revenues during the twelve calendar month period prior to your involvement from the sale
of advertising or sponsorships of pharmaceutical, OTC medicines, medical device and/or parenting/pregnancy products and services
or (ii) over l/3rd of their total revenues during the twelve calendar month period prior to your involvement from the
sale of advertising or sponsorships of pharmaceutical, OTC medicines, medical device and/or parenting/pregnancy products and services
and in each case your involvement will entail directly managing the sale of online/digital advertising or sponsorships of pharmaceutical,
OTC medicines, medical device and/or parenting/pregnancy products and services.
		(v)	Had over $20 million in advertising revenues during the twelve calendar month period prior to your involvement and your involvement
will entail directly managing the sale of online/digital advertising or sponsorships of pharmaceutical, OTC medicines, medical
device and/or parenting/pregnancy products and services.
		(vi)	Were formed/founded after January 1, 2012 and the business model for such entity anticipates more than l/3rd of
their total revenues to come from the sale of advertising or sponsorships of pharmaceutical, medical device and/or parenting/pregnancy
products and services during the Advisory Period.

 

For
the avoidance of doubt and without limiting the scope of the definition of “Conflicting Services” but subject to the
exceptions contained in the next paragraph, the following companies provide “Conflicting Services” as of the date of
this Agreement: (a) WebMD; (b) Yahoo; (c) AOL; (d) Drugsite Trust (Drugs.com); (e) Health Grades; (f) Healthline Networks; (g)
Marketing Technology Solutions (Quality Health); (h) Remedy Health Media; (i) Sharecare; (j) Demand Media (LIVESTRONG/eHoq); (k)
Rodale; and (I) Weight Watchers. Notwithstanding anything else in this Agreement, the non-competition restriction for WebMD shall
extend beyond the Advisory Period and continue until December 31, 2017.

 

Notwithstanding
the foregoing, the following in and of themselves shall not constitute work or services performed by you for a business that provides
“Conflicting Services”:

 

		(I)	ownership of an ownership interest in a private or publicly-traded entity that provides Conflicting
Services or owns an entity that provides Conflicting Services, provided such ownership interest does not exceed 10% of the fully-diluted
common equity;
	 	 	 
		(II)	serving as an officer, director, employee or consultant to an entity that provides Conflicting
Services or owns an entity that provides Conflicting Service along with other bona fide business, so long as you do not, directly
or indirectly, render material advice or services to the Conflicting Services portion of such business as described in clauses
(i)-(iii) and (vi) above or render the prohibited services in the case of clauses (iv) and (v) above; and

    	A-3

    	

    

(III) ownership of a non-controlling
investment made in a bona fide investment fund or similar vehicle that owns an interest in an entity that
provides Conflicting Services.

 

(e) “Customer
or Potential Customer” means each and every person and/or entity who or which, at any time during the two (2)
years prior to termination of your employment whom or which you knew or should have been aware: (i) contracted for, was billed
for, or received services from the Company, or (ii) was in contact with you or in contact with another representative of the Company
concerning the Company’s products and services.

    	A-4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}]]